Skip to main content

Poliomyelitis Vaccine - Novel Oral (nOPV) Type 2

Product overview

Type
Polio Vaccine - Novel Oral (nOPV) Type 2
Commercial Name
Polio Vaccine - Novel Oral (nOPV) Type 2
Manufacturer
PT Bio Farma (Persero)
Manufacturer Country
Indonesia
Responsible NRA
National Agency of Drug and Food Control Indonesia
Country
Indonesia

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
50
Diluent
Not Applicable
Route of Administration
Oral
Shelf Life
24 months
Storage Temperature
-20 °C ± 3 °C. The vaccine can also be stored for up to 6 months between +2 °C and +8 °C.
Vaccine Vial Monitor
Type 2
Secondary Packaging
Carton of 10 vials (500 doses). Dimensions: 11.5 x 4.7 x 5.1 cm
Tertiary Packaging
Box containing 1470 vials (73500 doses). Dimensions 65 x 51 x 60 cm
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
none
Cold Chain Volume
0.55 cm3/dose (in secondary packaging)

Attachments

Package Insert